Hamel Associates Inc. lessened its stake in AbbVie Inc. ( NYSE:ABBV – Get Rating ) by 0.9% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 27,711 shares of the company's stock after selling 250 shares during the quarter. AbbVie accounts for about 1.6% of Hamel Associates Inc.'s portfolio, making the stock its 26th largest holding. Hamel Associates Inc.'s holdings in AbbVie were worth $4,478,000 as of its most recent filing with the Securities & Exchange Commission.

https://www.dailypolitical.com/2023/04/26/abbvie-inc-nyseabbv-shares-sold-by-hamel-associates-inc.html

#dailypolitical